APA (7th ed.) Citation

K, K., N, O., M, F., & M, F. (2019). Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion. Dove Medical Press.

Chicago Style (17th ed.) Citation

K, Kumagai, Ogino N, Fukami M, and Furukawa M. Long-term Outcomes of Intravitreous Bevacizumab or Tissue Plasminogen Activator or Vitrectomy for Macular Edema Due to Branch Retinal Vein Occlusion. Dove Medical Press, 2019.

MLA (8th ed.) Citation

K, Kumagai, et al. Long-term Outcomes of Intravitreous Bevacizumab or Tissue Plasminogen Activator or Vitrectomy for Macular Edema Due to Branch Retinal Vein Occlusion. Dove Medical Press, 2019.